New drug could extend life of prostate cancer patients by 'two years'

   Download Android App    Share in      FullScreen   CheckVideos

Some men with advanced prostate cancer could survive for at least two more years on immunotherapy, according to a new study.

Unlimited Portal Access + Monthly Magazine - 12 issues

Monthly Magazine : $100.00 USD - yearly

---

Contribute US to Start Broadcasting - It's Voluntary!

ADVERTISE